The European Medicines Agency (EMA) found no specific risk factors, including age, for the AstraZeneca Covid jab, but said it was carrying out further analysis. This comes amid a bitter row between the UK and the bloc over coronavirus vaccine supplies.
EMA executive director Emer Cooke said in a statement: "EMA is of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects.
"A causal link with the vaccine is not proven.”
He added how they will continue to look at any evidence and will provide another update next week.
The AstraZeneca vaccine - which was developed with Oxford University - was approved for use by EU regulators earlier this year.
Germany, France, Italy and Spain all halted the use of the vaccine amid growing concerns as EU member states have recorded a number of blood clots after the vaccine was administered to patients.
Portugal, Slovenia, Cyprus, the Netherlands, Ireland, Denmark, Sweden, Romania, Latvia, Austria, Lithuania, Luxembourg and Bulgaria also all halted the inoculation of the jab, despite advice from the EMA.
Iceland and Norway, who are both not members of the EU but have joined the European Economic Area (EEA), also halted the AstraZeneca vaccine.
The row between the UK and the EU has been escalating since the Commission threatened Britain with a ban on vaccine exports.
READ MORE: Germans rage at Angela Merkel's AstraZeneca flipflopping - VIDEO
Mrs von der Leyen said: "I think it is clear that first of all the company has to catch up.
"[It] has to honour the contract it has with European member states before it can engage again in exporting vaccines.
"We want to explain to our European citizens that they [can] get their fair share."
Mr Johnson warned the "blockades" were "not sensible".
The EU's glacial vaccine rollout has been widely criticised by its own member states.
This week, Ireland's Taoiseach Micheal Martin hit back at the bloc and accused them of holding them back.
He said: "Every effort has been made to ensure that almost all doses are injected into people in the same week that they arrive, but disruptions to supply – to Ireland and throughout Europe – have held us back.
"Indeed, the only thing that is holding us back is supply."
To date, just 11.3 percent of adults aged 18 and above have received their first dose of a coronavirus vaccine across the EU.
Only 4.9 percent of adults from EU countries have been fully vaccinated.
In comparison, more than half of the adult population in the UK have received their first dose of a vaccine as the figure exceeds 30,000,000.
More than 3,000,000 people have received both jabs.
https://news.google.com/__i/rss/rd/articles/CBMiggFodHRwczovL3d3dy5leHByZXNzLmNvLnVrL25ld3Mvd29ybGQvMTQxNzQ0NS9Bc3RyYVplbmVjYS12YWNjaW5lLW5ld3Mtc2FmZS1FVS1yZWd1bGF0b3ItRU1BLXJlcG9ydC1sYXRlc3Qtbm8tcmlzay1mYWN0b3ItQ292aWQtamFi0gGGAWh0dHBzOi8vd3d3LmV4cHJlc3MuY28udWsvbmV3cy93b3JsZC8xNDE3NDQ1L0FzdHJhWmVuZWNhLXZhY2NpbmUtbmV3cy1zYWZlLUVVLXJlZ3VsYXRvci1FTUEtcmVwb3J0LWxhdGVzdC1uby1yaXNrLWZhY3Rvci1Db3ZpZC1qYWIvYW1w?oc=5
2021-03-31 14:38:00Z
52781475288725
Tidak ada komentar:
Posting Komentar